Vaxcyte, Inc. (PCVX) — Stock Score Summary

Vaxcyte, Inc. (PCVX) has a MoatMap StockRank of 42/100 based on Quality (39/100), Value (38/100), and Momentum (52/100) factor scores. The current signal is HOLD. Vaxcyte is a high-potential clinical-stage vaccine developer, but lacks the current cash flows, owner earnings, and commercial-stage moat required for our concentrated book.

Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel vaccines to prevent or treat infectious diseases. Its lead programs target pneumococcal disease and other bacterial infections, utilizing its proprietary cell-free protein synthesis platform. The company's competitive differentiation lies in its innovative platform technology, which aims to produce more effective and broader-spectrum vaccines.

Key Financial Metrics

Price$46.88
Market Cap$7.4B
P/E (Forward)-6.57
Price/Book2.35
Return on Equity-30.6%
Return on Invested Capital-33.0%
Debt/Equity3.88
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-440M

Vaxcyte, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Vaxcyte, Inc.’s (PCVX) StockRank?
MoatMap’s StockRank for Vaxcyte, Inc. (PCVX) is 42/100, with a Hold signal. It is a composite of Quality (39), Value (38), and Momentum (52) factor ranks across MoatMap’s 19,000+ stock universe.
Does Vaxcyte, Inc. have an economic moat?
Vaxcyte, Inc. (PCVX) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vaxcyte, Inc. a buy, hold, or sell?
MoatMap’s current signal for Vaxcyte, Inc. (PCVX) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vaxcyte, Inc. in?
Vaxcyte, Inc. (PCVX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksPCVX deep dive reportAI ChampionsHow we score stocksSense-check another stock